The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.

Essential Hypertension Clinical Trial

— SORT  

Official title:

A Non Interventional, Cross Sectional, Study on the Prevalence of Sympathetic Overactivity in Hypertensive Patients.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01295021
• Other study ID #: NIS-CIN-DUM-2010/2
• Status: Completed
• Phase: N/A
• First received: February 3, 2011
• Last updated: June 7, 2013
• Start date: February 2011
• Est. completion date: February 2012

Study information

• Verified date: June 2013
• Source: AstraZeneca
• Contact: n/a
• Is FDA regulated: No
• Health authority: India: Drugs Controller General of India
• Study type: Observational

Clinical Trial Summary

The purpose of this NIS is to assess the prevalence of sympathetic overactivity in patients with newly diagnosed essential hypertension.

Description:

MC MD

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1514
• Est. completion date: February 2012
• Est. primary completion date: February 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Newly diagnosed essential hypertension patients will be eligible for the study.

• Average of two or more systolic BP readings = 140mmHg or diastolic BP readings = 90mmHg

Exclusion Criteria:

• History of coronary artery disease

• History of diabetes

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Essential Hypertension
• Hypertension

Locations

Country	Name	City	State
India	Research Site	Agartala
India	Research Site	Agra
India	Research Site	Ahmedabad
India	Research Site	Aligarh
India	Research Site	Ambattur
India	Research Site	Amritsar
India	Research Site	Aurangabad
India	Research Site	Bangalore
India	Research Site	Barelly
India	Research Site	Baroda
India	Research Site	Batanagar
India	Research Site	Beed
India	Research Site	Belgaum
India	Research Site	Bhagal
India	Research Site	Bhongi
India	Research Site	Bhopal
India	Research Site	Bhuj
India	Research Site	Burdwan
India	Research Site	Chandigarh
India	Research Site	Chennai
India	Research Site	Chomv
India	Research Site	Coimbatore
India	Research Site	Davangere
India	Research Site	Delhi
India	Research Site	Dhule
India	Research Site	Dombivli
India	Research Site	Ellisbridge
India	Research Site	Fariadad
India	Research Site	Faridabad
India	Research Site	Gandhinagar
India	Research Site	Ghatkopar East
India	Research Site	Ghaziabad
India	Research Site	Gulbarga
India	Research Site	Guntur
India	Research Site	Gurgaon
India	Research Site	Gwalior
India	Research Site	Hanamkonda
India	Research Site	Hooghly
India	Research Site	Hubli
India	Research Site	Hyd
India	Research Site	Hyderabad
India	Research Site	Indore
India	Research Site	Jabalpur
India	Research Site	Jaipur
India	Research Site	Jalandhar
India	Research Site	Jalgoon
India	Research Site	Kakinada
India	Research Site	Kanpur
India	Research Site	Karad
India	Research Site	Karimnagar
India	Research Site	Kolhapur
India	Research Site	Kolkata
India	Research Site	Kolkata-
India	Research Site	Kulhapu
India	Research Site	Kumta
India	Research Site	Lucknow
India	Research Site	Ludhiana
India	Research Site	Madhyamgram
India	Research Site	Madurai
India	Research Site	Miroj
India	Research Site	Mohali
India	Research Site	Mozda
India	Research Site	Mrit Home
India	Research Site	Mulund
India	Research Site	Mumbai
India	Research Site	Murshidabad
India	Research Site	Nadiad
India	Research Site	Nagpur
India	Research Site	Nasik
India	Research Site	Naugloi
India	Research Site	Navi Mumbai
India	Research Site	Nesul
India	Research Site	New Delhi
India	Research Site	New Panvel
India	Research Site	Newdelhi
India	Research Site	Nipani
India	Research Site	Op Inchapur
India	Research Site	Palanpur
India	Research Site	Panvel.
India	Research Site	Parganas (Wb)
India	Research Site	Pune
India	Research Site	Raipur
India	Research Site	Rajkot
India	Research Site	Sahibabad,Gzb
India	Research Site	Secenderabad
India	Research Site	Shakar Pur
India	Research Site	Shimoga
India	Research Site	Sonarpur
India	Research Site	Sowcarpet
India	Research Site	Surat
India	Research Site	Thane
India	Research Site	Tirupati
India	Research Site	Ulhasnagar
India	Research Site	Vadodara
India	Research Site	Vijayawada
India	Research Site	Virar
India	Research Site	Visakhapatnam
India	Research Site	Vizag
India	Research Site	Warangal

Sponsors (1)

Lead Sponsor	Collaborator
AstraZeneca

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of SO in newly diagnosed hypertensive patients		Visit 1-3: heart rate & Blood pressure, treatment presribed by physician. The interval between visit 1 and visit 2 is upto 4 weeks and interval between visit 2 & visit 3 is upto 4 weeks depending on Investigators discretion.	No
Secondary	Association of SO and heart rate.		Visits 1-3	No
Secondary	Subjective symptoms noticed by the doctor.		1st visit	No
Secondary	To record the drugs used in the treatment of patients diagnosed with hypertension.		Visits 1-3	No